Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Phamacopeia scientists claim new IL-8 receptor modulators

Sep. 28, 2004

New antitumor agents and their use in ALL therapy

Sep. 28, 2004

Novel glucagon antagonists covered by Merck patent

Sep. 28, 2004

New peptide sulfonamides and their use as integrin receptor modulators

Sep. 28, 2004

Pfizer researchers describe new cannabinoid CB1 antagonists

Sep. 27, 2004

New antitumor, antibacterial and antifungal agents isolated from Streptomyces sp.

Sep. 27, 2004

Novel DPP-IV inhibitors and their use in type 2 diabetes claimed by Merck

Sep. 27, 2004

Oxazepine-based antitumor agents newly discovered at Servier

Sep. 27, 2004

Novel HDL-increasing agents developed at Eisai

Sep. 27, 2004

Novel PDE4 inhibitors prepared and tested at Kyowa Hakko

Sep. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...